KLK3 and posterior cortical atrophy: Data presented by the Surveillance, Epidemiological, and End Results registry have estimated that screening for PCa, using prostate-specific antigen (PSA) alone, resulted in an increase of 28% of patients being over-diagnosed in the US (11).